Azarkeivan A - Search Results

1

Evaluation of Efficacy, Safety, and Satisfaction Taking Deferasirox Twice Daily Versus Once Daily in Patients With Transfusion-Dependent Thalassemia.

Karimi M, Haghpanah S, Bahoush G, Ansari S, Azarkeivan A, Shahsavani A, Bazrafshan A, Jangjou A. Karimi M, et al. Among authors: azarkeivan a. J Pediatr Hematol Oncol. 2020 Jan;42(1):23-26. doi: 10.1097/MPH.0000000000001596. J Pediatr Hematol Oncol. 2020. PMID: 31568183 Clinical Trial.

2

Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants.

Ansari S, Azarkeivan A, Tabaroki A. Ansari S, et al. Among authors: azarkeivan a. Pediatr Hematol Oncol. 2006 Jan-Feb;23(1):33-7. doi: 10.1080/08880010500313306. Pediatr Hematol Oncol. 2006. PMID: 16326410

3

Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.

Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pakbaz Z, Tabatabaie SM, Bouzari N, Pourzahedgilani N, Azarkeivan A, Hashemi SR, Moosavi F, Alebouyeh M, Vosough P, Kimiagar M, Shamshirsaz AA, Moradi M, Habibzadeh MR, Nobakhthaghighi N, Larijani B. Shamshirsaz AA, et al. Among authors: azarkeivan a. Pediatr Hematol Oncol. 2007 Oct-Nov;24(7):469-79. doi: 10.1080/08880010701533702. Pediatr Hematol Oncol. 2007. PMID: 17786783

4

Endocrinopathies in patients with transfusion-dependent beta-thalassemia.

Mehrvar A, Azarkeivan A, Faranoush M, Mehrvar N, Saberinedjad J, Ghorbani R, Vossough P. Mehrvar A, et al. Among authors: azarkeivan a. Pediatr Hematol Oncol. 2008 Apr-May;25(3):187-94. doi: 10.1080/08880010801938207. Pediatr Hematol Oncol. 2008. PMID: 18432501

5

Pulmonary function test in transfusion-dependent beta-thalassemia patients.

Azarkeivan A, Mehrvar A, Pour HS, Mehrvar N, Vosough P. Azarkeivan A, et al. Pediatr Hematol Oncol. 2008 Sep;25(6):598-606. doi: 10.1080/08880010802237294. Pediatr Hematol Oncol. 2008. PMID: 18728979

6

Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).

Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A. Azarkeivan A, et al. Pediatr Hematol Oncol. 2009 Jun;26(4):195-201. doi: 10.1080/08880010902895900. Pediatr Hematol Oncol. 2009. PMID: 19437322

7

Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.

Karimi M, Giti R, Haghpanah S, Azarkeivan A, Hoofar H, Eslami M. Karimi M, et al. Among authors: azarkeivan a. Pediatr Blood Cancer. 2009 Dec;53(6):1064-7. doi: 10.1002/pbc.22144. Pediatr Blood Cancer. 2009. PMID: 19533641

8

A report of 8 cases with hemoglobin H disease in an Iranian family.

Azarkeivan A, Neishabury M, Hadavi V, Esteghamat F, Enrahimkhani S, Najmabadi H. Azarkeivan A, et al. Pediatr Hematol Oncol. 2010 Aug;27(5):405-12. doi: 10.3109/08880010903536201. Pediatr Hematol Oncol. 2010. PMID: 20670167

9

Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.

Azarkeivan A, Ansari S, Ahmadi MH, Hajibeigy B, Maghsudlu M, Nasizadeh S, Shaigan M, Toolabi A, Salahmand M. Azarkeivan A, et al. Pediatr Hematol Oncol. 2011 Sep;28(6):479-85. doi: 10.3109/08880018.2011.568595. Pediatr Hematol Oncol. 2011. PMID: 21854216

10

The incidence of hepatitis C in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study.

Azarkeivan A, Toosi MN, Maghsudlu M, Kafiabad SA, Hajibeigi B, Hadizadeh M. Azarkeivan A, et al. Transfusion. 2012 Aug;52(8):1814-8. doi: 10.1111/j.1537-2995.2012.03652.x. Epub 2012 Apr 15. Transfusion. 2012. PMID: 22500658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page